Literature DB >> 29603480

Chemoenzymatic Synthesis of Asymmetrical Multi-Antennary N-Glycans to Dissect Glycan-Mediated Interactions between Human Sperm and Oocytes.

Zoeisha S Chinoy1, Frédéric Friscourt1, Chantelle J Capicciotti1, Philip Chiu2, Geert-Jan Boons1,3,4,5.   

Abstract

Complex N-glycans of glycoproteins of the zona pellucida (ZP) of human oocytes have been implicated in the binding of spermatozoa. The termini of these unusual bi-, tri-, and tetra-antennary N-glycans consist of the tetrasaccharide sialyl-Lewisx (SLex ), which was previously identified as the minimal epitope for sperm binding. We describe here the chemoenzymatic synthesis of highly complex triantennary N-glycans derived from ZP carrying SLex moieties at the C-2 and C-2' arm and a sialyl-Lewisx -Lewisx (SLex -Lex ) residue at the C-6 antenna and two closely related analogues. The compounds were examined for their ability to inhibit the interaction of human sperm to ZP. It was found that the SLex -Lex moiety is critical for inhibitory activity, whereas the other SLex moieties exerted minimal effect. Further studies with SLex -Lex and SLex showed that the extended structure is the more potent inhibitor. In addition, trivalent SLex -Lex and SLex were prepared which showed greater inhibitory activity compared to their monovalent counterparts. Our studies show that although SLex can inhibit the binding of spermatozoa, presenting this epitope in the context of a complex N-glycan results in a loss of inhibitory potential, and in this context only SLex -Lex can make productive interactions. It is not the multivalent display of SLex on a multi-antennary glycan but the presentation of multiple SLex -Lex on the various glycosylation sites of ZP that accounts for high avidity binding.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  N-glycans; biochemistry; glycosyltransferases; multivalency; oocytes; sperm

Mesh:

Substances:

Year:  2018        PMID: 29603480      PMCID: PMC5986622          DOI: 10.1002/chem.201800451

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  32 in total

1.  A general strategy for the chemoenzymatic synthesis of asymmetrically branched N-glycans.

Authors:  Zhen Wang; Zoeisha S Chinoy; Shailesh G Ambre; Wenjie Peng; Ryan McBride; Robert P de Vries; John Glushka; James C Paulson; Geert-Jan Boons
Journal:  Science       Date:  2013-07-26       Impact factor: 47.728

2.  Human sperm binding is mediated by the sialyl-Lewis(x) oligosaccharide on the zona pellucida.

Authors:  Poh-Choo Pang; Philip C N Chiu; Cheuk-Lun Lee; Lan-Yi Chang; Maria Panico; Howard R Morris; Stuart M Haslam; Kay-Hooi Khoo; Gary F Clark; William S B Yeung; Anne Dell
Journal:  Science       Date:  2011-08-18       Impact factor: 47.728

Review 3.  From lectin structure to functional glycomics: principles of the sugar code.

Authors:  Hans-Joachim Gabius; Sabine André; Jesús Jiménez-Barbero; Antonio Romero; Dolores Solís
Journal:  Trends Biochem Sci       Date:  2011-04-01       Impact factor: 13.807

Review 4.  Multivalent glycoconjugates as anti-pathogenic agents.

Authors:  Anna Bernardi; Jesus Jiménez-Barbero; Alessandro Casnati; Cristina De Castro; Tamis Darbre; Franck Fieschi; Jukka Finne; Horst Funken; Karl-Erich Jaeger; Martina Lahmann; Thisbe K Lindhorst; Marco Marradi; Paul Messner; Antonio Molinaro; Paul V Murphy; Cristina Nativi; Stefan Oscarson; Soledad Penadés; Francesco Peri; Roland J Pieters; Olivier Renaudet; Jean-Louis Reymond; Barbara Richichi; Javier Rojo; Francesco Sansone; Christina Schäffer; W Bruce Turnbull; Trinidad Velasco-Torrijos; Sébastien Vidal; Stéphane Vincent; Tom Wennekes; Han Zuilhof; Anne Imberty
Journal:  Chem Soc Rev       Date:  2012-12-19       Impact factor: 54.564

5.  A revised structure for fucoidan may explain some of its biological activities.

Authors:  M S Patankar; S Oehninger; T Barnett; R L Williams; G F Clark
Journal:  J Biol Chem       Date:  1993-10-15       Impact factor: 5.157

6.  Poly N-acetyllactosamine substitutions on N- and not O-oligosaccharides or Thomsen-Friedenreich antigen facilitate lung specific metastasis of melanoma cells via galectin-3.

Authors:  Nithya Srinivasan; Sanjay M Bane; Shashikant D Ahire; Arvind D Ingle; Rajiv D Kalraiya
Journal:  Glycoconj J       Date:  2008-10-24       Impact factor: 2.916

7.  Synthesis of multiantennary complex type N-glycans by use of modular building blocks.

Authors:  Carlo Unverzagt; Gislinde Gundel; Steffen Eller; Ralf Schuberth; Joachim Seifert; Harald Weiss; Mathäus Niemietz; Matthias Pischl; Claudia Raps
Journal:  Chemistry       Date:  2009-11-16       Impact factor: 5.236

8.  Carbohydrate analysis of the zona pellucida and cortical granules of human oocytes by means of ultrastructural cytochemistry.

Authors:  María Jiménez-Movilla; Manuel Avilés; María José Gómez-Torres; Pedro José Fernández-Colom; María Teresa Castells; Joaquín de Juan; Alberto Romeu; José Ballesta
Journal:  Hum Reprod       Date:  2004-06-24       Impact factor: 6.918

Review 9.  Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research.

Authors:  Thomas J Boltje; Therese Buskas; Geert-Jan Boons
Journal:  Nat Chem       Date:  2009-11       Impact factor: 24.427

Review 10.  Notable Aspects of Glycan-Protein Interactions.

Authors:  Miriam Cohen
Journal:  Biomolecules       Date:  2015-09-01
View more
  3 in total

Review 1.  Oligosaccharide Synthesis and Translational Innovation.

Authors:  Larissa Krasnova; Chi-Huey Wong
Journal:  J Am Chem Soc       Date:  2019-02-18       Impact factor: 15.419

Review 2.  Recent Progress in Chemo-Enzymatic Methods for the Synthesis of N-Glycans.

Authors:  Qiang Chao; Yi Ding; Zheng-Hui Chen; Meng-Hai Xiang; Ning Wang; Xiao-Dong Gao
Journal:  Front Chem       Date:  2020-06-16       Impact factor: 5.221

3.  A Clickable Bioorthogonal Sydnone-Aglycone for the Facile Preparation of a Core 1 O-Glycan-Array.

Authors:  Zoeisha S Chinoy; Kelley W Moremen; Frédéric Friscourt
Journal:  European J Org Chem       Date:  2022-05-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.